Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit or (NCT04508621).

Stock Info
: Analyst Coverage

Analyst Coverage

Firm Analyst
Alliance Global Partners James Molloy
Zacks Small-Cap Research David Bautz, PhD


Tonix Pharmaceuticals Holding Corp. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Tonix Pharmaceuticals Holding Corp.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tonix Pharmaceuticals Holding Corp. or its management. Tonix Pharmaceuticals Holding Corp. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.